Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,928.90 ($23.47) and traded as high as GBX 2,102 ($25.57). Hikma Pharmaceuticals shares last traded at GBX 2,091.92 ($25.45), with a volume of 345,375 shares.
Hikma Pharmaceuticals Stock Performance
The stock has a market cap of £4.64 billion, a P/E ratio of 3,218.34, a price-to-earnings-growth ratio of 2.38 and a beta of 0.41. The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.48. The stock has a 50 day simple moving average of GBX 1,949.17 and a 200 day simple moving average of GBX 1,928.90.
Hikma Pharmaceuticals Company Profile
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Why Invest in 5G? How to Invest in 5G Stocks
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Russell 2000 Index, How Investors Use it For Profitable Trading
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What is a Bond Market Holiday? How to Invest and Trade
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
